All Industry articles – Page 14
View all stories with this category.
-
-
Business
Mylan settles Epipen overcharging allegations
Company will pay US Department of Justice $465m for avoiding paying rebates to government healthcare systems
-
Research
Fluorescent test strip detects deadly phosgene gas
Portable test checks for industrial gas leaks and chemical attacks
-
Opinion
Make room for randomness in drug development
Setting free the dark horses sometimes beats the most rational planning
-
Business
Airgas fined for fatal nitrogen leak at US sperm bank
$300,000 penalty for leak caused by over-pressurisation after Airgas failed to update tank safety label
-
Business
Chemical and pharma bosses quit US manufacturing council
President Trump disbands the group after multiple advisers resign in protest against his stance on racism
-
Business
US court denies Amgen appeal over Pfizer biosimilar
Amgen has lost its bid to compel Pfizer to divulge information about its version of anaemia drug Epogen
-
Business
Chemical companies urged to update cyber defences
Outdated technology is leaving chemical, energy and petrochemical facilities vulnerable to ransomware attacks
-
Business
GSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
-
Business
Genesis Energy to buy alkali business from Tronox
Tronox to spend proceeds on Cristal purchase
-
News
Trump and Dow Chemical chief executive clashed on climate
White House adviser and head of US’s largest chemical firm, Andrew Liveris, tried to change the president’s mind on Paris accord
-
Opinion
(+)-Pleuromutilin
Total synthesis is sometimes the only way to explore the chemical space around a natural product
-
Business
Consortium working to extend sustainable coconut oil supply chain
Agricultural education programme helps secure production and reduce environmental impact
-
Business
Broad Institute backs central Crispr patent licensing platform
Key players submit 22 patents to pool, and urge other holders to create a one-stop shop for licensing deals
-
Business
Lilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
Business
Mallinckrodt settles US opioid lawsuit
Firm will pay $35m over allegations it failed to report suspicious orders of controlled substances
-
Business
Arkema invests in speciality chemicals
Company will expand Asian plants producing bio-based polyamide, thiochemicals and photocured resins
-
Opinion
Making enough of a difference
What if the needle in the drug development haystack ends up being too small to be useful?
-
Business
FDA approves first sickle cell drug in almost two decades
Glutamine-based drug is the first approved for children over 5
-
Business
EU to investigate Merck KGaA’s merger with Sigma–Aldrich
Commission says Merck failed to disclose a crucial research project
